Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$249K Buy
1,434
+210
+17% +$43K ﹤0.01% 1117
2025
Q4
$339K Sell
1,224
-38
-3% -$9.96K ﹤0.01% 991
2025
Q3
$328K Sell
1,262
-3
-0.2% -$789 ﹤0.01% 1002
2025
Q2
$309K Sell
1,265
-5
-0.4% -$1.25K ﹤0.01% 997
2025
Q1
$336K Sell
1,270
-85
-6% -$23K ﹤0.01% 944
2024
Q4
$344K Sell
1,355
-641
-32% -$172K ﹤0.01% 964
2024
Q3
$632K Sell
1,996
-29
-1% -$10.3K 0.01% 749
2024
Q2
$757K Buy
2,025
+337
+20% +$114K 0.01% 666
2024
Q1
$585K Sell
1,688
-1,918
-53% -$727K 0.01% 751
2023
Q4
$1.65M Buy
3,606
+679
+23% +$335K 0.03% 435
2023
Q3
$1.42M Buy
2,927
+626
+27% +$294K 0.03% 453
2023
Q2
$1.03M Buy
2,301
+86
+4% +$43.3K 0.02% 544
2023
Q1
$1.08M Sell
2,215
-3,812
-63% -$1.88M 0.02% 516
2022
Q4
$3.09M Buy
6,027
+364
+6% +$191K 0.06% 289
2022
Q3
$2.75M Buy
5,663
+3,134
+124% +$1.52M 0.06% 311
2022
Q2
$1.18M Buy
2,529
+24
+1% +$10.7K 0.02% 488
2022
Q1
$1.09M Buy
2,505
+50
+2% +$20.9K 0.02% 575
2021
Q4
$1.14M Buy
2,455
+324
+15% +$143K 0.02% 590
2021
Q3
$829K Sell
2,131
-248
-10% -$105K 0.01% 707
2021
Q2
$1.05M Buy
2,379
+1,112
+88% +$486K 0.02% 644
2021
Q1
$531K Buy
1,267
+85
+7% +$33.9K 0.01% 817
2020
Q4
$485K Sell
1,182
-85
-7% -$35.3K 0.01% 788
2020
Q3
$524K Sell
1,267
-10
-0.8% -$4.02K 0.01% 721
2020
Q2
$495K Sell
1,277
-10
-0.8% -$3.74K 0.01% 704
2020
Q1
$404K Sell
1,287
-499
-28% -$168K 0.01% 700
2019
Q4
$655K Buy
1,786
+79
+5% +$25.1K 0.01% 659
2019
Q3
$436K Buy
1,707
+313
+22% +$87.8K 0.01% 790
2019
Q2
$370K Buy
1,394
+55
+4% +$13.9K 0.01% 843
2019
Q1
$356K Sell
1,339
-30
-2% -$8.64K 0.01% 856
2018
Q4
$392K Buy
1,369
+447
+48% +$142K 0.01% 767
2018
Q3
$312K Hold
922
0.01% 919
2018
Q2
$274K Hold
922
0.01% 731
2018
Q1
$248K Hold
922
0.01% 609
2017
Q4
$229K Sell
922
-10
-1% -$2.47K 0.01% 615
2017
Q3
$227K Sell
932
-25
-3% -$6.13K 0.01% 638
2017
Q2
$230K Buy
+957
New +$217K 0.01% 762

Other funds holding HUM

Stephens Inc's HUM Position: Q1 2026 in Review

Stephens Inc increased its Humana (HUM) stake by 17% in Q1 2026, buying an estimated $43K and bringing the position to 1,434 shares worth $249K. The position accounts for ﹤0.01% of the portfolio, ranked #1117.

Stephens Inc first reported a position in HUM in Q2 2017 and has held it in 36 quarters since. The position peaked at $3.09M in Q4 2022. 779 funds tracked by Wall St. Rank hold HUM as of Q1 2026.

  • Stephens Inc held 1,434 shares of Humana worth $249K as of Q1 2026.
  • Stephens Inc bought 210 Humana shares in Q1 2026, an estimated $43K.
  • Humana made up ﹤0.01% of Stephens Inc's portfolio in Q1 2026, its #1117 holding.
  • Stephens Inc first reported a position in Humana in Q2 2017 and has held it in 36 quarters since.
  • Stephens Inc's Humana position peaked at $3.09M in Q4 2022.
  • 779 funds tracked by Wall St. Rank held Humana as of Q1 2026.

Based on Stephens Inc's 13F filing for Q1 2026, filed 28 Apr 2026.